Skip to main content

Table 5 Cost-effectiveness analysis of expanded NBS covering 12 IEMs

From: Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology

Strategy

Ea

Incr. Eb

Cc

Incr. Cd

Incr. C/Incr. E

C/E

Expanded Screening

74.247

0.00078

478.430

217.756

277,823

6.444

Current Screening

74.246

 

260.674

  

3.511

  1. aE Effectiveness,
  2. bIncr. E Incremental Effectiveness,
  3. cC cost,
  4. dIncr. C Incremental Cost
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us